Statement of Work No. 1 Provider ServicesProvider Services • January 5th, 2022 • Context Therapeutics Inc. • Pharmaceutical preparations
This SOW (“SOW”), dated as of January 1, 2022 (the “SOW Effective Date”), is subject to that certain Master Services Agreement, effective as of January 1, 2022 (the “Agreement”), by and between Drug and Device Development Solutions LLC, a North Carolina Limited Liability Corporation, having its principal place of business at [***] (“Provider”), and Context Therapeutics Inc., having offices at 3675 Market Street, Suite 200, Philadelphia, PA 19104 (“Company”). The terms and provisions of the Agreement are incorporated by reference into this SOW and Provider agrees to be bound by all terms and provisions of the Agreement applicable hereto. Capitalized terms used in this SOW and not defined shall have the meanings ascribed to them in the Agreement.
MASTER SERVICES AGREEMENTMaster Services Agreement • January 5th, 2022 • Context Therapeutics Inc. • Pharmaceutical preparations • Pennsylvania
THIS MASTER SERVICES AGREEMENT (this “Agreement”) is entered into and effective as of January 1, 2022 (the “Effective Date”) by and between Drug and Device Development Solutions LLC, a North Carolina Limited Liability Corporation, having its principal place of business at [***] (“Provider”), and Context Therapeutics Inc., having offices at 3675 Market Street, Suite 200, Philadelphia, PA 19104 (“Company”). Provider and the Company may each be referred to herein as a “Party” and collectively, the “Parties”. In consideration of the mutual covenants, terms, and conditions contained in this Agreement, the Parties agree as follows:
